Rol de las enfermeras en la notificación de reacciones adversas medicamentosas

  1. Ana Zurita-Garaicoechea
  2. Reis Carvalho, Joana
  3. Ripa Aisa, Irantzu
  4. Jiménez Mendoza, Ana
  5. Díaz Balén, Almudena
  6. Oroviogoicoechea Ortega, Cristina
Revista:
Enfermería clínica

ISSN: 1130-8621

Año de publicación: 2015

Volumen: 25

Número: 5

Páginas: 239-244

Tipo: Artículo

DOI: 10.1016/J.ENFCLI.2015.04.003 DIALNET GOOGLE SCHOLAR

Otras publicaciones en: Enfermería clínica

Objetivos de desarrollo sostenible

Resumen

Background The spontaneous report system, in which suspected adverse drug reaction (ADR) are reported by healthcare workers, is currently one of the primary methods to prevent and discover new and serious ADR to marketed medicinal products. The collaboration of nursing professionals with this task makes it possible to improve patient safety and to reduce ADR costs. Although a total of 781 cases of ADR cases were reported in Navarra in 2011, only 7.33% were reported by nurses. The objectives werw to determine the factors that influence nurses in reporting of ADR, and second, to devise strategies which help to increase reporting. Material and methods A bibliographic search for articles that included the words: reacciones adversas medicamentosas (adverse drug reactions), notificación (reporting) and enfermería (nursing) was conducted using the PubMed and Cinhal databases. A total of 107 articles were retrieved, of which 27 were selected according to inclusion and exclusion criteria. Results The conclusion learned by reading and analyzing the selected articles was that the factors that affect the notification depend on the attitude of the notifier, as well as personal and professional factors. The main strategies to encourage notification are education and training, motivation, and the availability of facilitating tools. Conclusions The main factors that have an influence on under-notification are the lack of knowledge and motivation among professionals. To solve the problem of under-notification, the main actions and strategies to undertake are education, motivation and persistence.

Referencias bibliográficas

  • BOE N.° 179. Real Decreto 577/2013, de 26 de julio, por el que se regula la farmacovigilancia de medicamentos de uso humano. Ministerio de Sanidad, Servicions Sociales e Igualdad, 27 de Julio de 2013. Pp. 55066-55092.
  • Backstrom M., Mjorndal T., Dahlqvist R. Under-reporting of serious adverse drug reactions in Sweden. Pharmacoepidemiol Drug Saf 2004, 13:483-487.
  • Otero M. Acontecimientos adversos por medicamentos: una patología emergente. Farmacia Hospitalaria 2000, 24:258.
  • Rottenkolber D., Schmiedl S., Rottenkolber M., Farker K., Salje K., Mueller S., et al. Adverse drug reactions in Germany: direct costs of internal medicine hospitalizations. Pharmacoepidemiol Drug Saf 2011, 20:626-634.
  • Montpart Costa E, Martín Barea MP. El Sistema Español de Farmacovigilancia [en línea]. [consultado 20 Nov 2012] Disponible en: http://www.dfarmacia.com.
  • Le J., Nguyen T., Law A.V., Hodding J. Adverse drug reactions among children over a 10-year period. Pediatrics 2006, 118:555-562.
  • BOE N.° 174. ORDEN CIN/2134/2008 de 3 de julio, por la que se establecen los requisitos para la verificación de los títulos universitarios oficiales que habiliten para el ejercicio de la profesión de Enfermero. Ministerio de Ciencia e Innovación. Madrid, España, 19 de julio de 2008. Pp.3168031681.
  • Boletín Informativo de Farmacovigilancia [Navarra]: Centro de farmacovigilancia de Navarra. Septiembre 2012. N.° 29. pp. 8-9.
  • Jimeno Demuth F.J., Manso Rodríguez G., González Iglesias V., Ordóñez Fernández L., Salgueiro Vázquez M.E. Farmacovigilancia y errores de medicación. ROL de Enfermería 2012, 35:168-178.
  • Lopez-Gonzalez E., Herdeiro M.T., Figueiras A. Determinants of under-reporting of adverse drug reactions: a systematic review. Drug Saf 2009, 32:19-31.
  • Desikan R, Krauss MJ, Dunagan WC, Rachmiel EC, Bailey T, Fraser VJ. Reporting of adverse drug events: examination of a hospital incident reporting system. En: Henriksen K, Battles JB, Marks ES, Lewin DI, editors. Advances in patient safety: from research to implementation (Volume 1: Research Findings). Rockville (MD): Agency for Healthcare Research and Quality (US); 2005.
  • Hazell L., Shakir S.A. Under-reporting of adverse drug reactions: a systematic review. Drug Saf 2006, 29:385-396.
  • Morrison-Griffiths S., Pirmohamed M. Specialist nurse reporting of adverse drug reactions. Prof Nurse 2000, 15:300-304.
  • Backstrom M., Mjorndal T., Dahlqvist R. Spontaneous reporting of adverse drug reactions by nurses. Pharmacoepidemiol Drug Saf 2002, 11:647-650.
  • Ekman E., Petersson G., Tagerud S., Backstrom M. Awareness among nurses about reporting of adverse drug reactions in Sweden. Drug Healthc Patient Saf 2012, 4:61-66.
  • Li Q., Zhang S.M., Chen H.T., Fang S.P., Yu X., Liu D., et al. Awareness and attitudes of healthcare professionals in Wuhan, China to the reporting of adverse drug reactions. Chin Med J (Engl) 2004, 117:856-861.
  • Tremlett H.L., Oger J. Ten years of adverse drug reaction reports for the multiple sclerosis immunomodulatory therapies: a Canadian perspective. Mult Scler 2008, 14:94-105.
  • Krahenbuhl-Melcher A., Schlienger R., Lampert M., Haschke M., Drewe J., Krahenbuhl S. Drugrelated problems in hospitals: a review of the recent literature. Drug Saf 2007, 30:379-407.
  • Ruud K.W., Srinivas S.C., Toverud E.L. Addressing gaps in pharmacovigilance practices in the antiretroviral therapy program in the Eastern Cape Province, South Africa. Res Social Adm Pharm 2010, 6:345-353.
  • Backstrom M., Ekman E., Mjorndal T. Adverse drug reaction reporting by nurses in Sweden. Eur J Clin Pharmacol 2007, 63:613-618.
  • Conforti A., Opri S., D'Incau P., Sottosanti L., Moretti U., Ferrazin F., et al. Adverse drug reaction reporting by nurses: analysis of Italian pharmacovigilance database. Pharmacoepidemiol Drug Saf 2012, 21:597-602.
  • Morrison-Griffiths S., Walley T.J., Park B.K., Breckenridge A.M., Pirmohamed M. Reporting of adverse drug reactions by nurses. Lancet 2003, 361:1347-1348.
  • Ekman E., Bäckström M. Attitudes among hospital physicians to the reporting of adverse drug reactions in Sweden. Eur J Clin Pharmacol 2009, 65:43-46.
  • Hunt J.M., Gjoka G. Nurse reporting of adverse events caused by medicines. Nurs Times 2003, 99:24-25.
  • Johansson M.L., Hagg S., Wallerstedt S.M. Impact of information letters on the reporting rate of adverse drug reactions and the quality of the reports: a randomized controlled study. BMC Clin Pharmacol 2011, 11:14.
  • John L.J., Arifulla M., Cheriathu J.J., Sreedharan J. Reporting of adverse drug reactions: an exploratory study among nurses in a teaching hospital, Ajman, United Arab Emirates. Daru 2012, 20:44.
  • Thurmann P.A. Methods and systems to detect adverse drug reactions in hospitals. Drug Saf 2001, 24:961-968.
  • Manso G., Thole Z., Salgueiro E., Revuelta P., Hidalgo A. Spontaneous reporting of hepatotoxicity associated with antiandrogens: data from the Spanish pharmacovigilance system. Pharmacoepidemiol Drug Saf 2006, 15:253-259.
  • Baldridge C. Which drug reactions should be reported? Edited version of an article published in the December 2005 edition of Practice Nursing. Pract Nurs 2008, 19:182-184.
Fuente de los datos: Dialnet